Hitomi Miyake

441 total citations
17 papers, 320 citations indexed

About

Hitomi Miyake is a scholar working on Molecular Biology, Ophthalmology and Oncology. According to data from OpenAlex, Hitomi Miyake has authored 17 papers receiving a total of 320 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Ophthalmology and 4 papers in Oncology. Recurrent topics in Hitomi Miyake's work include Bone health and treatments (4 papers), Retinal Diseases and Treatments (3 papers) and Glaucoma and retinal disorders (3 papers). Hitomi Miyake is often cited by papers focused on Bone health and treatments (4 papers), Retinal Diseases and Treatments (3 papers) and Glaucoma and retinal disorders (3 papers). Hitomi Miyake collaborates with scholars based in Japan. Hitomi Miyake's co-authors include Ippei Kanazawa, Toshitsugu Sugimoto, Dai Miyazaki, Yumiko Shimizu, Yoshitsugu Inoue, Ken-ichiro Tanaka, Shinichi Sasaki, Takashi Baba, Ryuichi Ideta and Naoki Komatsu and has published in prestigious journals such as Scientific Reports, Biochemical and Biophysical Research Communications and eLife.

In The Last Decade

Hitomi Miyake

16 papers receiving 315 citations

Peers

Hitomi Miyake

OPHTH

RNMI

OSM

ONCOL

Tian Xia China

Ji Hun Song South Korea

Kerstin Stähr Germany

Shinya Watanabe Japan

Andrei-Alexandru Szigiato Canada

Huiying Liu China

Maria Romana Bacarelli Italy

Adam Szczepanik Poland

S. Feldman–Billard France

Chul Han Kim South Korea

Tian Xia China

Hitomi Miyake

75 ×0.6

OPHTH

61 ×0.8

49 ×0.9

RNMI

69 ×1.3

OSM

39 ×0.8

ONCOL

Citations per year, relative to Hitomi Miyake Hitomi Miyake (= 1×) peers Tian Xia

Countries citing papers authored by Hitomi Miyake

Since Specialization

Citations

This map shows the geographic impact of Hitomi Miyake's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hitomi Miyake with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hitomi Miyake more than expected).

Fields of papers citing papers by Hitomi Miyake

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hitomi Miyake. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hitomi Miyake. The network helps show where Hitomi Miyake may publish in the future.

Co-authorship network of co-authors of Hitomi Miyake

This figure shows the co-authorship network connecting the top 25 collaborators of Hitomi Miyake. A scholar is included among the top collaborators of Hitomi Miyake based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hitomi Miyake. Hitomi Miyake is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Okanishi, Tohru, Masanobu Fujimoto, Hiroyuki Awano, et al.. (2025). Multidisciplinary Management of Plexiform Neurofibromas in Pediatric Patients With Neurofibromatosis 1: Insights From Advisory Board‐Guided Clinical Experience in Japan. The Journal of Dermatology. 53(1). 135–139.

Baba, Takashi, Hitomi Miyake, Shinichi Sasaki, et al.. (2023). Association of IL-4 with pachychoroid neovasculopathy. Scientific Reports. 13(1). 1152–1152. 3 indexed citations

Makino, Hirofumi, Masakazu Notsu, Miwa Morita, et al.. (2022). Successful Control of Hypercalcemia with Sorafenib, Evocalcet, and Denosumab Combination Therapy for Recurrent Parathyroid Carcinoma. Internal Medicine. 61(22). 3383–3390. 9 indexed citations

Miyazaki, Dai, Yuji Nakagawa, Yuji Ayatsuka, et al.. (2021). Determination of probability of causative pathogen in infectious keratitis using deep learning algorithm of slit-lamp images. Scientific Reports. 11(1). 22642–22642. 44 indexed citations

Baba, Takashi, Dai Miyazaki, Hitomi Miyake, et al.. (2020). Role of IL-4 in bone marrow driven dysregulated angiogenesis and age-related macular degeneration. eLife. 9. 23 indexed citations

Morita, Miwa, Hitomi Miyake, Masahiro Yamamoto, et al.. (2020). A case of insulin-like growth factor 2-producing gastrointestinal stromal tumor with severe hypoglycemia. BMC Endocrine Disorders. 20(1). 60–60. 10 indexed citations

Kanazawa, Ippei, et al.. (2019). A scoring assessment tool for the risk of vertebral fractures in patients with type 2 diabetes mellitus. Bone. 122. 38–44. 6 indexed citations

Miyake, Hitomi, Dai Miyazaki, Yumiko Shimizu, et al.. (2019). Toxicities of and inflammatory responses to moxifloxacin, cefuroxime, and vancomycin on retinal vascular cells. Scientific Reports. 9(1). 9745–9745. 19 indexed citations

Miyake, Hitomi, Ippei Kanazawa, Ken-ichiro Tanaka, & Toshitsugu Sugimoto. (2019). Low skeletal muscle mass is associated with the risk of all-cause mortality in patients with type 2 diabetes mellitus. Therapeutic Advances in Endocrinology and Metabolism. 10. 2388763547–2388763547. 35 indexed citations

10.

Miyazaki, Dai, Hitomi Miyake, Naoki Komatsu, et al.. (2018). High interleukin-8 level in aqueous humor is associated with poor prognosis in eyes with open angle glaucoma and neovascular glaucoma. Scientific Reports. 8(1). 14533–14533. 55 indexed citations

11.

Miyake, Hitomi, Ippei Kanazawa, & Toshitsugu Sugimoto. (2018). Albuminuria Increases All-Cause Mortality in Japanese Patients with Type 2 Diabetes Mellitus. Journal of Clinical Medicine. 7(9). 234–234. 4 indexed citations

12.

Miyake, Hitomi, Ippei Kanazawa, & Toshitsugu Sugimoto. (2017). Association of Bone Mineral Density, Bone Turnover Markers, and Vertebral Fractures with All-Cause Mortality in Type 2 Diabetes Mellitus. Calcified Tissue International. 102(1). 1–13. 46 indexed citations

13.

Takeno, Ayumu, Ippei Kanazawa, Miwa Morita, et al.. (2017). A case report of fulminant type 1 diabetes mellitus associated with drug-induced hypersensitivity syndrome in an elderly patient with coxsackie B4 virus infection and human leukocyte antigen-A24 haplotype. Endocrine Journal. 65(1). 129–132. 10 indexed citations

14.

Miyake, Hitomi, Ippei Kanazawa, & Toshitsugu Sugimoto. (2017). Decreased Serum Insulin-like Growth Factor-I is a Risk Factor for Non-vertebral Fractures in Diabetic Postmenopausal Women. Internal Medicine. 56(3). 269–273. 15 indexed citations

15.

Miyake, Hitomi, Ippei Kanazawa, & Toshitsugu Sugimoto. (2016). Low skeletal muscle mass is associated with increased mortality in postmenopausal women with type 2 diabetes mellitus. Diabetes Research and Clinical Practice. 120. S83–S84. 1 indexed citations

16.

Miyake, Hitomi, Ippei Kanazawa, & Toshitsugu Sugimoto. (2016). Decreased serum insulin-like growth factor-I level is associated with the increased mortality in type 2 diabetes mellitus. Endocrine Journal. 63(9). 811–818. 10 indexed citations

17.

Nagahama, Masami, Takayuki Matsui, Hitomi Miyake, et al.. (2009). UBXD1 is a VCP-interacting protein that is involved in ER-associated degradation. Biochemical and Biophysical Research Communications. 382(2). 303–308. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact